Evaluation of risk-reducing salpingo-oophorectomy for patients with BRCA 1/2 mutation

Evaluation of risk-reducing salpingo-oophorectomy for patients with BRCA 1/2 mutation - Evaluation of RRSO for patients with BRCA 1/2 mutation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000023606

Enrollment

Registered

2016-08-12

Start date

2016-08-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hereditary breast and ovarian cancer: HBOC

Interventions

risk reducing salpingo-oophorectomy

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: patients with deleterious familial mutation of BRCA 1/2

Exclusion criteria

Exclusion criteria: no mutation of BRCA1/2

Design outcomes

Primary

Measure	Time frame
1)safety of RRSO 2)5year overall survival	—

Countries

Japan

Contacts

Public ContactHidekatsu Nakai

Kindai University Hospital Obstetrics and gynecology

sanfu@med.kindai.ac.jp072-366-0221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026